Skip to Content
Merck
CN

PBS1

Phosphate Buffered Saline System

Sign In to View Organizational & Contract Pricing.

Select a Size

Change View

About This Item

UNSPSC Code:
12161700
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist


form

liquid

solubility

water: soluble

Packaging

Set of stock solutions for preparing custom PBS buffers


Kit Components Only

Product No.
Description

  • 1M KH2PO4 1 L

  • 1M K2HPO4 1 L

  • 5M NaCl 1 L

Storage Class

10 - Combustible liquids

wgk

WGK 1

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

Eyeshields, Gloves, multi-purpose combination respirator cartridge (US)

Regulatory Information

新产品

This item has



Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our Documents section.

If you need assistance, please contact Customer Support

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library


Related Content

Instructions


Silvana Ramos Atayde et al.
PloS one, 13(7), e0201106-e0201106 (2018-07-31)
Because collagen type V (Col V) can be exposed in tissue injury, we hypothesized that oral administration of this collagen species modulates the inflammation and remodeling of experimental synovitis, avoiding joint destruction, and that the modulation may differ according to
Laura Millares et al.
International journal of chronic obstructive pulmonary disease, 12, 2807-2811 (2017-10-17)
The bronchial mucosa is protected by a specialized immune system focused on the prevention of colonization and infection by potentially pathogenic microorganisms (PPMs). Immunoglobulin A (IgA) is the principal antibody involved in this mechanism. A defective immune barrier may facilitate
Stine Spray et al.
Journal of molecular neuroscience : MN, 61(3), 396-411 (2016-12-10)
This study aimed at obtaining an in-depth mapping of expressional changes of the cerebral microvasculature after transient global cerebral ischemia (GCI) and the impact on these GCI-induced expressional changes of post-GCI treatment with a mitogen-activated protein kinase kinase (MEK1/2) inhibitor.